The systemic status of redox (reduction/oxidation) in glaucoma has been a subject of interest after the identification of the circulating autoantibodies against antioxidative stress enzymes and chaperone molecules glutathione S-transferase [27], and heat shock proteins [28,29] in the serum of patients with glaucoma. This evidence concerns the gene HPGDS and glaucoma.